Recent VYGR News
- Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting • GlobeNewswire Inc. • 05/08/2024 10:00:00 AM
- Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 05/06/2024 11:00:00 AM
- Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting • GlobeNewswire Inc. • 04/22/2024 08:30:00 PM
- Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment • GlobeNewswire Inc. • 04/16/2024 11:00:00 AM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/26/2024 08:01:00 PM
- Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results • GlobeNewswire Inc. • 02/28/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:00:24 PM
- Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment • GlobeNewswire Inc. • 02/26/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:36:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:30:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 08:16:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 08:13:39 PM
- Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast • GlobeNewswire Inc. • 02/21/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 08:11:54 PM
- Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research • GlobeNewswire Inc. • 02/20/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:06:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:04:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:03:00 PM
- Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference • GlobeNewswire Inc. • 02/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:34:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:32:36 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 01/17/2024 09:20:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/17/2024 08:33:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/17/2024 08:21:38 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM